Effects of constant rate infusion of a fixed-dose combination of medetomidine and vatinoxan on sedation, cardiorespiratory variables, and gastrointestinal activity in standing Thoroughbred horses.
BACKGROUND A fixed-dose combination of medetomidine (MED) and vatinoxan (VTX), a peripherally selective α2-adrenoceptor antagonist, is commercially available, but its constant rate infusion (CRI) has not been evaluated. AIMS/OBJECTIVES To compare the sedative effects, cardiorespiratory variables, and gastrointestinal...